English
简体中文
Total: £ 56.28
Published Date: 2024-04-08 | Pages: 79 | Tables: 178 | Pharma & Healthcare
The global Sunitinib Malate Capsules market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Sunitinib Malate Capsules is an anticancer drug commonly used in the treatment of gastrointestinal tumors. Its market overview mainly includes the following aspects:
a. Market demand: Gastrointestinal tumors are increasing, so the demand for drugs to treat tumors is also increasing. Sunitinib malate capsules, as an effective tumor treatment drug, are favored by clinicians and patients.
b. Competitive situation: There are other similar anti-cancer drugs on the market, and the field of drug development is constantly advancing and innovating. Therefore, Sunitinib Malate Capsules is facing competitive pressure from competitors.
c. Market size: The market size of sunitinib malate capsules is relatively large. With the increase of tumor diseases and patients' demand for more effective therapeutic drugs, the market size is expected to continue to grow.
Generally speaking, sunitinib malate capsules have great market potential, but at the same time, they also need to face competition pressure and changes in market demand.
This report aims to provide a comprehensive presentation of the global market for Sunitinib Malate Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sunitinib Malate Capsules.
Report Scope
The Sunitinib Malate Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sunitinib Malate Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sunitinib Malate Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Topcare Pharmaceutical Co., Ltd
Nanjing First Pharmaceutical Co., Ltd.
J&K Scientific
Target Molecule Corp.
Teva Pharmaceuticals USA
CSPC Pharmaceutical Group Limited
Segment by Type
Purity>99%
Purity>98%
Purity>97%
Segment by Application
Advanced Kidney Cancer
GIST (Gastrointestinal Stromal Tumor)
Pancreatic Neuroendocrine Tumors
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sunitinib Malate Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sunitinib Malate Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Sunitinib Malate Capsules Market Overview
1.1 Product Overview and Scope of Sunitinib Malate Capsules
1.2 Sunitinib Malate Capsules Segment by Type
1.2.1 Global Sunitinib Malate Capsules Market Value Comparison by Type (2024-2030)
1.2.2 Purity>99%
1.2.3 Purity>98%
1.2.4 Purity>97%
1.3 Sunitinib Malate Capsules Segment by Application
1.3.1 Global Sunitinib Malate Capsules Market Value by Application: (2024-2030)
1.3.2 Advanced Kidney Cancer
1.3.3 GIST (Gastrointestinal Stromal Tumor)
1.3.4 Pancreatic Neuroendocrine Tumors
1.3.5 Others
1.4 Global Sunitinib Malate Capsules Market Size Estimates and Forecasts
1.4.1 Global Sunitinib Malate Capsules Revenue 2019-2030
1.4.2 Global Sunitinib Malate Capsules Sales 2019-2030
1.4.3 Global Sunitinib Malate Capsules Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Sunitinib Malate Capsules Market Competition by Manufacturers
2.1 Global Sunitinib Malate Capsules Sales Market Share by Manufacturers (2019-2024)
2.2 Global Sunitinib Malate Capsules Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Sunitinib Malate Capsules Average Price by Manufacturers (2019-2024)
2.4 Global Sunitinib Malate Capsules Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sunitinib Malate Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sunitinib Malate Capsules, Product Type & Application
2.7 Sunitinib Malate Capsules Market Competitive Situation and Trends
2.7.1 Sunitinib Malate Capsules Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sunitinib Malate Capsules Players Market Share by Revenue
2.7.3 Global Sunitinib Malate Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sunitinib Malate Capsules Retrospective Market Scenario by Region
3.1 Global Sunitinib Malate Capsules Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Sunitinib Malate Capsules Global Sunitinib Malate Capsules Sales by Region: 2019-2030
3.2.1 Global Sunitinib Malate Capsules Sales by Region: 2019-2024
3.2.2 Global Sunitinib Malate Capsules Sales by Region: 2025-2030
3.3 Global Sunitinib Malate Capsules Global Sunitinib Malate Capsules Revenue by Region: 2019-2030
3.3.1 Global Sunitinib Malate Capsules Revenue by Region: 2019-2024
3.3.2 Global Sunitinib Malate Capsules Revenue by Region: 2025-2030
3.4 North America Sunitinib Malate Capsules Market Facts & Figures by Country
3.4.1 North America Sunitinib Malate Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Sunitinib Malate Capsules Sales by Country (2019-2030)
3.4.3 North America Sunitinib Malate Capsules Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sunitinib Malate Capsules Market Facts & Figures by Country
3.5.1 Europe Sunitinib Malate Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Sunitinib Malate Capsules Sales by Country (2019-2030)
3.5.3 Europe Sunitinib Malate Capsules Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sunitinib Malate Capsules Market Facts & Figures by Country
3.6.1 Asia Pacific Sunitinib Malate Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Sunitinib Malate Capsules Sales by Country (2019-2030)
3.6.3 Asia Pacific Sunitinib Malate Capsules Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Sunitinib Malate Capsules Market Facts & Figures by Country
3.7.1 Latin America Sunitinib Malate Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Sunitinib Malate Capsules Sales by Country (2019-2030)
3.7.3 Latin America Sunitinib Malate Capsules Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sunitinib Malate Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Sunitinib Malate Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Sunitinib Malate Capsules Sales by Country (2019-2030)
3.8.3 Middle East and Africa Sunitinib Malate Capsules Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sunitinib Malate Capsules Sales by Type (2019-2030)
4.1.1 Global Sunitinib Malate Capsules Sales by Type (2019-2024)
4.1.2 Global Sunitinib Malate Capsules Sales by Type (2025-2030)
4.1.3 Global Sunitinib Malate Capsules Sales Market Share by Type (2019-2030)
4.2 Global Sunitinib Malate Capsules Revenue by Type (2019-2030)
4.2.1 Global Sunitinib Malate Capsules Revenue by Type (2019-2024)
4.2.2 Global Sunitinib Malate Capsules Revenue by Type (2025-2030)
4.2.3 Global Sunitinib Malate Capsules Revenue Market Share by Type (2019-2030)
4.3 Global Sunitinib Malate Capsules Price by Type (2019-2030)
5 Segment by Application
5.1 Global Sunitinib Malate Capsules Sales by Application (2019-2030)
5.1.1 Global Sunitinib Malate Capsules Sales by Application (2019-2024)
5.1.2 Global Sunitinib Malate Capsules Sales by Application (2025-2030)
5.1.3 Global Sunitinib Malate Capsules Sales Market Share by Application (2019-2030)
5.2 Global Sunitinib Malate Capsules Revenue by Application (2019-2030)
5.2.1 Global Sunitinib Malate Capsules Revenue by Application (2019-2024)
5.2.2 Global Sunitinib Malate Capsules Revenue by Application (2025-2030)
5.2.3 Global Sunitinib Malate Capsules Revenue Market Share by Application (2019-2030)
5.3 Global Sunitinib Malate Capsules Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Sunitinib Malate Capsules Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Sunitinib Malate Capsules Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Topcare Pharmaceutical Co., Ltd
6.2.1 Topcare Pharmaceutical Co., Ltd Corporation Information
6.2.2 Topcare Pharmaceutical Co., Ltd Description and Business Overview
6.2.3 Topcare Pharmaceutical Co., Ltd Sunitinib Malate Capsules Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Topcare Pharmaceutical Co., Ltd Sunitinib Malate Capsules Product Portfolio
6.2.5 Topcare Pharmaceutical Co., Ltd Recent Developments/Updates
6.3 Nanjing First Pharmaceutical Co., Ltd.
6.3.1 Nanjing First Pharmaceutical Co., Ltd. Corporation Information
6.3.2 Nanjing First Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Capsules Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Capsules Product Portfolio
6.3.5 Nanjing First Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 J&K Scientific
6.4.1 J&K Scientific Corporation Information
6.4.2 J&K Scientific Description and Business Overview
6.4.3 J&K Scientific Sunitinib Malate Capsules Sales, Revenue and Gross Margin (2019-2024)
6.4.4 J&K Scientific Sunitinib Malate Capsules Product Portfolio
6.4.5 J&K Scientific Recent Developments/Updates
6.5 Target Molecule Corp.
6.5.1 Target Molecule Corp. Corporation Information
6.5.2 Target Molecule Corp. Description and Business Overview
6.5.3 Target Molecule Corp. Sunitinib Malate Capsules Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Target Molecule Corp. Sunitinib Malate Capsules Product Portfolio
6.5.5 Target Molecule Corp. Recent Developments/Updates
6.6 Teva Pharmaceuticals USA
6.6.1 Teva Pharmaceuticals USA Corporation Information
6.6.2 Teva Pharmaceuticals USA Description and Business Overview
6.6.3 Teva Pharmaceuticals USA Sunitinib Malate Capsules Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Pharmaceuticals USA Sunitinib Malate Capsules Product Portfolio
6.6.5 Teva Pharmaceuticals USA Recent Developments/Updates
6.7 CSPC Pharmaceutical Group Limited
6.6.1 CSPC Pharmaceutical Group Limited Corporation Information
6.6.2 CSPC Pharmaceutical Group Limited Description and Business Overview
6.6.3 CSPC Pharmaceutical Group Limited Sunitinib Malate Capsules Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CSPC Pharmaceutical Group Limited Sunitinib Malate Capsules Product Portfolio
6.7.5 CSPC Pharmaceutical Group Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sunitinib Malate Capsules Industry Chain Analysis
7.2 Sunitinib Malate Capsules Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sunitinib Malate Capsules Production Mode & Process
7.4 Sunitinib Malate Capsules Sales and Marketing
7.4.1 Sunitinib Malate Capsules Sales Channels
7.4.2 Sunitinib Malate Capsules Distributors
7.5 Sunitinib Malate Capsules Customers
8 Sunitinib Malate Capsules Market Dynamics
8.1 Sunitinib Malate Capsules Industry Trends
8.2 Sunitinib Malate Capsules Market Drivers
8.3 Sunitinib Malate Capsules Market Challenges
8.4 Sunitinib Malate Capsules Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Sunitinib Malate Capsules Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Sunitinib Malate Capsules Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Sunitinib Malate Capsules Market Competitive Situation by Manufacturers in 2023
Table 4. Global Sunitinib Malate Capsules Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Sunitinib Malate Capsules Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Sunitinib Malate Capsules Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Sunitinib Malate Capsules Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Sunitinib Malate Capsules Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Sunitinib Malate Capsules, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Sunitinib Malate Capsules, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Sunitinib Malate Capsules, Product Type & Application
Table 12. Global Key Manufacturers of Sunitinib Malate Capsules, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sunitinib Malate Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sunitinib Malate Capsules as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Sunitinib Malate Capsules Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Sunitinib Malate Capsules Sales by Region (2019-2024) & (K Units)
Table 18. Global Sunitinib Malate Capsules Sales Market Share by Region (2019-2024)
Table 19. Global Sunitinib Malate Capsules Sales by Region (2025-2030) & (K Units)
Table 20. Global Sunitinib Malate Capsules Sales Market Share by Region (2025-2030)
Table 21. Global Sunitinib Malate Capsules Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Sunitinib Malate Capsules Revenue Market Share by Region (2019-2024)
Table 23. Global Sunitinib Malate Capsules Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Sunitinib Malate Capsules Revenue Market Share by Region (2025-2030)
Table 25. North America Sunitinib Malate Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Sunitinib Malate Capsules Sales by Country (2019-2024) & (K Units)
Table 27. North America Sunitinib Malate Capsules Sales by Country (2025-2030) & (K Units)
Table 28. North America Sunitinib Malate Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Sunitinib Malate Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Sunitinib Malate Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Sunitinib Malate Capsules Sales by Country (2019-2024) & (K Units)
Table 32. Europe Sunitinib Malate Capsules Sales by Country (2025-2030) & (K Units)
Table 33. Europe Sunitinib Malate Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Sunitinib Malate Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Sunitinib Malate Capsules Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Sunitinib Malate Capsules Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Sunitinib Malate Capsules Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Sunitinib Malate Capsules Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Sunitinib Malate Capsules Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Sunitinib Malate Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Sunitinib Malate Capsules Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Sunitinib Malate Capsules Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Sunitinib Malate Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Sunitinib Malate Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Sunitinib Malate Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Sunitinib Malate Capsules Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Sunitinib Malate Capsules Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Sunitinib Malate Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Sunitinib Malate Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Sunitinib Malate Capsules Sales (K Units) by Type (2019-2024)
Table 51. Global Sunitinib Malate Capsules Sales (K Units) by Type (2025-2030)
Table 52. Global Sunitinib Malate Capsules Sales Market Share by Type (2019-2024)
Table 53. Global Sunitinib Malate Capsules Sales Market Share by Type (2025-2030)
Table 54. Global Sunitinib Malate Capsules Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Sunitinib Malate Capsules Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Sunitinib Malate Capsules Revenue Market Share by Type (2019-2024)
Table 57. Global Sunitinib Malate Capsules Revenue Market Share by Type (2025-2030)
Table 58. Global Sunitinib Malate Capsules Price (US$/Unit) by Type (2019-2024)
Table 59. Global Sunitinib Malate Capsules Price (US$/Unit) by Type (2025-2030)
Table 60. Global Sunitinib Malate Capsules Sales (K Units) by Application (2019-2024)
Table 61. Global Sunitinib Malate Capsules Sales (K Units) by Application (2025-2030)
Table 62. Global Sunitinib Malate Capsules Sales Market Share by Application (2019-2024)
Table 63. Global Sunitinib Malate Capsules Sales Market Share by Application (2025-2030)
Table 64. Global Sunitinib Malate Capsules Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Sunitinib Malate Capsules Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Sunitinib Malate Capsules Revenue Market Share by Application (2019-2024)
Table 67. Global Sunitinib Malate Capsules Revenue Market Share by Application (2025-2030)
Table 68. Global Sunitinib Malate Capsules Price (US$/Unit) by Application (2019-2024)
Table 69. Global Sunitinib Malate Capsules Price (US$/Unit) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Sunitinib Malate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Sunitinib Malate Capsules Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Topcare Pharmaceutical Co., Ltd Corporation Information
Table 76. Topcare Pharmaceutical Co., Ltd Description and Business Overview
Table 77. Topcare Pharmaceutical Co., Ltd Sunitinib Malate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Topcare Pharmaceutical Co., Ltd Sunitinib Malate Capsules Product
Table 79. Topcare Pharmaceutical Co., Ltd Recent Developments/Updates
Table 80. Nanjing First Pharmaceutical Co., Ltd. Corporation Information
Table 81. Nanjing First Pharmaceutical Co., Ltd. Description and Business Overview
Table 82. Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Capsules Product
Table 84. Nanjing First Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 85. J&K Scientific Corporation Information
Table 86. J&K Scientific Description and Business Overview
Table 87. J&K Scientific Sunitinib Malate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. J&K Scientific Sunitinib Malate Capsules Product
Table 89. J&K Scientific Recent Developments/Updates
Table 90. Target Molecule Corp. Corporation Information
Table 91. Target Molecule Corp. Description and Business Overview
Table 92. Target Molecule Corp. Sunitinib Malate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Target Molecule Corp. Sunitinib Malate Capsules Product
Table 94. Target Molecule Corp. Recent Developments/Updates
Table 95. Teva Pharmaceuticals USA Corporation Information
Table 96. Teva Pharmaceuticals USA Description and Business Overview
Table 97. Teva Pharmaceuticals USA Sunitinib Malate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Teva Pharmaceuticals USA Sunitinib Malate Capsules Product
Table 99. Teva Pharmaceuticals USA Recent Developments/Updates
Table 100. CSPC Pharmaceutical Group Limited Corporation Information
Table 101. CSPC Pharmaceutical Group Limited Description and Business Overview
Table 102. CSPC Pharmaceutical Group Limited Sunitinib Malate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. CSPC Pharmaceutical Group Limited Sunitinib Malate Capsules Product
Table 104. CSPC Pharmaceutical Group Limited Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Sunitinib Malate Capsules Distributors List
Table 108. Sunitinib Malate Capsules Customers List
Table 109. Sunitinib Malate Capsules Market Trends
Table 110. Sunitinib Malate Capsules Market Drivers
Table 111. Sunitinib Malate Capsules Market Challenges
Table 112. Sunitinib Malate Capsules Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Sunitinib Malate Capsules
Figure 2. Global Sunitinib Malate Capsules Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Sunitinib Malate Capsules Market Share by Type in 2023 & 2030
Figure 4. Purity>99% Product Picture
Figure 5. Purity>98% Product Picture
Figure 6. Purity>97% Product Picture
Figure 7. Global Sunitinib Malate Capsules Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Sunitinib Malate Capsules Market Share by Application in 2023 & 2030
Figure 9. Advanced Kidney Cancer
Figure 10. GIST (Gastrointestinal Stromal Tumor)
Figure 11. Pancreatic Neuroendocrine Tumors
Figure 12. Others
Figure 13. Global Sunitinib Malate Capsules Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Sunitinib Malate Capsules Market Size (2019-2030) & (US$ Million)
Figure 15. Global Sunitinib Malate Capsules Sales (2019-2030) & (K Units)
Figure 16. Global Sunitinib Malate Capsules Average Price (US$/Unit) & (2019-2030)
Figure 17. Sunitinib Malate Capsules Report Years Considered
Figure 18. Sunitinib Malate Capsules Sales Share by Manufacturers in 2023
Figure 19. Global Sunitinib Malate Capsules Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Sunitinib Malate Capsules Players: Market Share by Revenue in 2023
Figure 21. Sunitinib Malate Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Sunitinib Malate Capsules Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Sunitinib Malate Capsules Sales Market Share by Country (2019-2030)
Figure 24. North America Sunitinib Malate Capsules Revenue Market Share by Country (2019-2030)
Figure 25. United States Sunitinib Malate Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Sunitinib Malate Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Sunitinib Malate Capsules Sales Market Share by Country (2019-2030)
Figure 28. Europe Sunitinib Malate Capsules Revenue Market Share by Country (2019-2030)
Figure 29. Germany Sunitinib Malate Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Sunitinib Malate Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Sunitinib Malate Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Sunitinib Malate Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Sunitinib Malate Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Sunitinib Malate Capsules Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Sunitinib Malate Capsules Revenue Market Share by Region (2019-2030)
Figure 36. China Sunitinib Malate Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Sunitinib Malate Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Sunitinib Malate Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Sunitinib Malate Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Sunitinib Malate Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Sunitinib Malate Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Sunitinib Malate Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Sunitinib Malate Capsules Sales Market Share by Country (2019-2030)
Figure 44. Latin America Sunitinib Malate Capsules Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Sunitinib Malate Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Sunitinib Malate Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Sunitinib Malate Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Sunitinib Malate Capsules Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Sunitinib Malate Capsules Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Sunitinib Malate Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Sunitinib Malate Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Sunitinib Malate Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Sunitinib Malate Capsules by Type (2019-2030)
Figure 54. Global Revenue Market Share of Sunitinib Malate Capsules by Type (2019-2030)
Figure 55. Global Sunitinib Malate Capsules Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Sunitinib Malate Capsules by Application (2019-2030)
Figure 57. Global Revenue Market Share of Sunitinib Malate Capsules by Application (2019-2030)
Figure 58. Global Sunitinib Malate Capsules Price (US$/Unit) by Application (2019-2030)
Figure 59. Sunitinib Malate Capsules Value Chain
Figure 60. Sunitinib Malate Capsules Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
